Under construction – not a live service
Sign in
Not yet recruitingNo phase

Interactive Technological Intervention to Improve Mental Health Symptoms in Primary Health Care

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
University of Sao Paulo General Hospital
Trial code
NCT06692842
Record updated
7 January 2026
Original description
This study aims to implement and evaluate a technological intervention called CONEMO to treat depressive symptoms, anxiety, and insomnia in adults who use primary health care services. The effectiveness of this intervention has already been proven in previous research, specifically for depressive symptoms. Implementation will occur in 28 basic health units in the municipalities of Indiatuba and Jaguariúna in the interior of São Paulo.Read full original descriptionShow less

Implementation Study of an Interactive Technological Intervention to Improve Mental Health Symptoms in Primary Health Care Users

This study aims to implement and evaluate a technological intervention called CONEMO to treat depressive symptoms, anxiety, and insomnia in adults who use primary health care services. The effectiveness of this intervention has already been proven in previous research, specifically for depressive symptoms. Implementation will occur in 28 basic health units in the municipalities of Indiatuba and Jaguariúna in the interior of São Paulo.

All eligible residents of the cities will be invited to participate.

Inclusion: Look for consultation in basic health units due to Major Depressive Disorder, Insomnia and/or Generalized Anxiety Disorder, or who receive home visits for the same reason; Score \>= 10 on the PHQ-9 Scale for Depression; and/or \>= 11 on the IGI Scale for Insomnia; and/or \>= 10 on the GAD-7 Scale for Anxiety; Be able to read the app\'s instructions via a tablet or smartphone screen.

Exclusion: Individuals considered severe on the Suicide Risk Assessment Protocol-SRAP (suicidal imminence).

ClinicalTrials.gov NCT06692842